Mainstream Capital Management’s MetLife MET Stock Holding History

Mainstream Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$819	–	205
2024 Q4	$819	Buy	+10	New	+$832	﹤0.01%	301

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mainstream Capital Management's MET Position: Q1 2025 in Review

Mainstream Capital Management sold out of MetLife (MET) in Q1 2025, closing a stake of 10 shares — an estimated $819 sold.

Mainstream Capital Management first reported a position in MET in Q4 2024 and held it in 1 quarter. The position peaked at $819 in Q4 2024. 1,407 funds tracked by Wall St. Rank hold MET as of Q1 2025.

Mainstream Capital Management reported no remaining MetLife position as of Q1 2025 after selling out during the quarter.
Mainstream Capital Management sold 10 MetLife shares in Q1 2025, an estimated $819.
Mainstream Capital Management first reported a position in MetLife in Q4 2024 and held it in 1 quarter.
Mainstream Capital Management's MetLife position peaked at $819 in Q4 2024.
1,407 funds tracked by Wall St. Rank held MetLife as of Q1 2025.

Based on Mainstream Capital Management's 13F filing for Q1 2025, filed 28 Apr 2025.